Response to "<i>NLRC5</i> germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng.
第一作者:
Lilach,Aizenbud
第一单位:
Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.
作者:
主题词
人类(Humans);肿瘤(Neoplasms);生殖细胞系突变(Germ-Line Mutation);免疫(Immunity);生殖细胞(Germ Cells);细胞内信号肽和蛋白质类(Intracellular Signaling Peptides and Proteins)
DOI
10.1136/jitc-2023-007397
PMID
37349129
发布时间
2024-03-12
- 浏览0

Journal for immunotherapy of cancer
2023年11卷6期
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文